Since a similar chemotherapy resistance phenomenon has been observed in multiple NECs and related tumour types, we sought to understand whether SNAP25 plays a similar role in other NECs (including PNET, SINEC and SCLC) and tumours with similar molecular signatures. This evidence concerns the gene SNAP25 and neoplasm.